ATE256457T1 - In gelatine eingekapselte sertarline dosierungsformen - Google Patents

In gelatine eingekapselte sertarline dosierungsformen

Info

Publication number
ATE256457T1
ATE256457T1 AT98923021T AT98923021T ATE256457T1 AT E256457 T1 ATE256457 T1 AT E256457T1 AT 98923021 T AT98923021 T AT 98923021T AT 98923021 T AT98923021 T AT 98923021T AT E256457 T1 ATE256457 T1 AT E256457T1
Authority
AT
Austria
Prior art keywords
sertarline
gelatin
dosage forms
forms encapsulated
encapsulated
Prior art date
Application number
AT98923021T
Other languages
English (en)
Inventor
William John Curatolo
Ravi Mysore Shanker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE256457(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE256457T1 publication Critical patent/ATE256457T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT98923021T 1997-07-01 1998-06-16 In gelatine eingekapselte sertarline dosierungsformen ATE256457T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01
PCT/IB1998/000936 WO1999001113A1 (en) 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline

Publications (1)

Publication Number Publication Date
ATE256457T1 true ATE256457T1 (de) 2004-01-15

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98923021T ATE256457T1 (de) 1997-07-01 1998-06-16 In gelatine eingekapselte sertarline dosierungsformen

Country Status (40)

Country Link
EP (1) EP0980241B1 (de)
JP (1) JP3585245B2 (de)
KR (1) KR100371730B1 (de)
CN (1) CN1261792A (de)
AP (1) AP945A (de)
AR (1) AR015916A1 (de)
AT (1) ATE256457T1 (de)
AU (1) AU724635B2 (de)
BG (1) BG103917A (de)
BR (1) BR9809712A (de)
CA (1) CA2290973C (de)
CO (1) CO4940405A1 (de)
DE (1) DE69820608T2 (de)
DK (1) DK0980241T3 (de)
DZ (1) DZ2544A1 (de)
EA (1) EA001905B1 (de)
ES (1) ES2210760T3 (de)
GT (1) GT199800090A (de)
HR (1) HRP980378B1 (de)
HU (1) HUP0002250A3 (de)
ID (1) ID24673A (de)
IL (1) IL133075A0 (de)
IS (1) IS5266A (de)
MA (1) MA24586A1 (de)
MY (1) MY119728A (de)
NO (1) NO996492L (de)
NZ (1) NZ501252A (de)
OA (1) OA11246A (de)
PA (1) PA8454001A1 (de)
PE (1) PE97299A1 (de)
PL (1) PL337807A1 (de)
PT (1) PT980241E (de)
SK (1) SK282914B6 (de)
TN (1) TNSN98123A1 (de)
TR (1) TR199903282T2 (de)
TW (1) TW382597B (de)
UA (1) UA68350C2 (de)
UY (1) UY25070A1 (de)
WO (1) WO1999001113A1 (de)
ZA (1) ZA985709B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
KR100417200B1 (ko) * 1998-10-13 2004-02-05 화이자 프로덕츠 인코포레이티드 세트랄린 경구 농축물
DE122009000036I2 (de) 1999-09-03 2010-05-06 Apbi Holdings Llc Verwendung von Dapoxetin, ein selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Dysfunktion
AU2001276608A1 (en) 2000-08-30 2002-03-13 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
EP1375659A1 (de) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Konzentratmischungen in löslichen Kapseln zur einfachen Zubereitung von chemischen oder biologischen Lösungen
US20040142040A1 (en) * 2002-10-31 2004-07-22 Dong Liang C. Formulation and dosage form providing increased bioavailability of hydrophobic drugs
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2197554A1 (en) * 1994-09-19 1996-03-28 The Du Pont Merck Pharmaceutical Company Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
PT768083E (pt) * 1995-07-17 2003-08-29 Pfizer Sertralina para o tratamento de doentes pos-enfarte miocardico

Also Published As

Publication number Publication date
EP0980241A1 (de) 2000-02-23
CA2290973A1 (en) 1999-01-14
UY25070A1 (es) 2000-12-29
AU7545098A (en) 1999-01-25
AP9801279A0 (en) 1998-06-30
JP3585245B2 (ja) 2004-11-04
GT199800090A (es) 1999-12-21
MY119728A (en) 2005-07-29
MA24586A1 (fr) 1998-12-31
PE97299A1 (es) 1999-10-13
NO996492L (no) 2000-02-29
AU724635B2 (en) 2000-09-28
AR015916A1 (es) 2001-05-30
CO4940405A1 (es) 2000-07-24
ZA985709B (en) 2000-01-10
DE69820608D1 (de) 2004-01-29
PA8454001A1 (es) 2000-05-24
IL133075A0 (en) 2001-03-19
JP2000512316A (ja) 2000-09-19
DZ2544A1 (fr) 2003-02-08
DK0980241T3 (da) 2004-04-05
OA11246A (en) 2002-11-19
TNSN98123A1 (fr) 2005-03-15
ID24673A (id) 2000-07-27
EA199900963A1 (ru) 2000-08-28
CA2290973C (en) 2003-06-17
TW382597B (en) 2000-02-21
BR9809712A (pt) 2000-07-11
EA001905B1 (ru) 2001-10-22
WO1999001113A1 (en) 1999-01-14
PL337807A1 (en) 2000-09-11
HUP0002250A2 (hu) 2000-12-28
ES2210760T3 (es) 2004-07-01
HUP0002250A3 (en) 2001-01-29
PT980241E (pt) 2004-03-31
DE69820608T2 (de) 2004-12-23
SK282914B6 (sk) 2003-01-09
BG103917A (bg) 2000-07-31
KR100371730B1 (ko) 2003-02-07
TR199903282T2 (xx) 2000-08-21
SK180599A3 (en) 2001-01-18
NZ501252A (en) 2004-11-26
CN1261792A (zh) 2000-08-02
HRP980378B1 (en) 2001-12-31
UA68350C2 (en) 2004-08-16
EP0980241B1 (de) 2003-12-17
AP945A (en) 2001-02-28
NO996492D0 (no) 1999-12-27
IS5266A (is) 1999-11-23
KR20010013588A (ko) 2001-02-26
HRP980378A2 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
NO944046D0 (no) Ökning av medikamentrespons
FI956073A (fi) Pehmeäkuoriset gelatiiniin kapseloidut osaset
BR9407178A (pt) Cápsula de gelatina
DK0815855T3 (da) Flerfaset blød gelatine-doseringsform
DE69530301D1 (de) Implantierbarer sensor-chip
DE69821525D1 (de) Photochrome pyrano-kondensierte naphthopyrane
DE69820407D1 (de) Blisterpackung
FR2730933B1 (fr) Capsule de gelatine molle
ATE255409T1 (de) Cisplatinhaltige mikrogranulate
DE69800225T2 (de) Kapselmaschine
DK1017392T3 (da) Lægemiddel
DK1025107T3 (da) Fotokrome forbindelser
ATE256457T1 (de) In gelatine eingekapselte sertarline dosierungsformen
DE69636433D1 (de) Halbleiterspeicher mit arithmetikfunktion
FI964335A (fi) Kotelo
DK0818964T3 (da) Doseringsstift
DE29715802U1 (de) Schluckbrunnen
FI960099A (fi) Pehmeäkuoriseen gelatiinikapseliin kapseloituja partikkeleita
DE69822263D1 (de) Fotografisches Entwicklungsgerät
DE29609185U1 (de) Beruhigungsschaukel
KR970046953U (ko) 칩 내장 패키지
DE69821827D1 (de) Photographisches Entwicklungsgerät
DE69811421T2 (de) Fehlertolerante Speicher
DE29515557U1 (de) Chip mit radialsymmetrischer Kontaktanordnung
DE29814038U1 (de) Gelatineartikel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0980241

Country of ref document: EP

REN Ceased due to non-payment of the annual fee